Jennison Associates’s Aratana Therapeutics PETX Stock Holding History
Bought
Maintained
Sold
Other funds holding PETX
AIC
Jennison Associates's PETX Position: Q2 2017 in Review
Jennison Associates sold out of Aratana Therapeutics (PETX) in Q2 2017, closing a stake of 975,369 shares — an estimated $5.17M sold.
Jennison Associates first reported a position in PETX in Q2 2013 and held it in 16 quarters. The position peaked at $55.8M in Q4 2014. 105 funds tracked by Wall St. Rank hold PETX as of Q2 2017.
- Jennison Associates reported no remaining Aratana Therapeutics position as of Q2 2017 after selling out during the quarter.
- Jennison Associates sold 975,369 Aratana Therapeutics shares in Q2 2017, an estimated $5.17M.
- Jennison Associates first reported a position in Aratana Therapeutics in Q2 2013 and held it in 16 quarters.
- Jennison Associates's Aratana Therapeutics position peaked at $55.8M in Q4 2014.
- 105 funds tracked by Wall St. Rank held Aratana Therapeutics as of Q2 2017.
Based on Jennison Associates's 13F filing for Q2 2017, filed 4 Aug 2017.